Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review

Toxic shock syndrome (TSS) is an uncommon complication of infection caused by streptococci and staphylococci. It is associated with a high mortality rate. When evaluating patients with shock symptoms from skin or soft tissue sources, a high index of suspicion for TSS must be maintained. Prompt diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Amreen, Sana, Brar, Simrandeep K, Perveen, Sumera, Chaudhry, Muhammad Reza, AlBabtain, Sarah, Khan, Safeera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896483/
https://www.ncbi.nlm.nih.gov/pubmed/33628694
http://dx.doi.org/10.7759/cureus.12836
_version_ 1783653552264052736
author Amreen, Sana
Brar, Simrandeep K
Perveen, Sumera
Chaudhry, Muhammad Reza
AlBabtain, Sarah
Khan, Safeera
author_facet Amreen, Sana
Brar, Simrandeep K
Perveen, Sumera
Chaudhry, Muhammad Reza
AlBabtain, Sarah
Khan, Safeera
author_sort Amreen, Sana
collection PubMed
description Toxic shock syndrome (TSS) is an uncommon complication of infection caused by streptococci and staphylococci. It is associated with a high mortality rate. When evaluating patients with shock symptoms from skin or soft tissue sources, a high index of suspicion for TSS must be maintained. Prompt diagnosis and integrative management with surgical intervention, antibiotics, hemodynamic stabilization, and adjuvants like intravenous immunoglobulins improve survival.
format Online
Article
Text
id pubmed-7896483
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-78964832021-02-23 Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review Amreen, Sana Brar, Simrandeep K Perveen, Sumera Chaudhry, Muhammad Reza AlBabtain, Sarah Khan, Safeera Cureus Internal Medicine Toxic shock syndrome (TSS) is an uncommon complication of infection caused by streptococci and staphylococci. It is associated with a high mortality rate. When evaluating patients with shock symptoms from skin or soft tissue sources, a high index of suspicion for TSS must be maintained. Prompt diagnosis and integrative management with surgical intervention, antibiotics, hemodynamic stabilization, and adjuvants like intravenous immunoglobulins improve survival. Cureus 2021-01-21 /pmc/articles/PMC7896483/ /pubmed/33628694 http://dx.doi.org/10.7759/cureus.12836 Text en Copyright © 2021, Amreen et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Amreen, Sana
Brar, Simrandeep K
Perveen, Sumera
Chaudhry, Muhammad Reza
AlBabtain, Sarah
Khan, Safeera
Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review
title Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review
title_full Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review
title_fullStr Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review
title_full_unstemmed Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review
title_short Clinical Efficacy of Intravenous Immunoglobulins in Management of Toxic Shock Syndrome: An Updated Literature Review
title_sort clinical efficacy of intravenous immunoglobulins in management of toxic shock syndrome: an updated literature review
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896483/
https://www.ncbi.nlm.nih.gov/pubmed/33628694
http://dx.doi.org/10.7759/cureus.12836
work_keys_str_mv AT amreensana clinicalefficacyofintravenousimmunoglobulinsinmanagementoftoxicshocksyndromeanupdatedliteraturereview
AT brarsimrandeepk clinicalefficacyofintravenousimmunoglobulinsinmanagementoftoxicshocksyndromeanupdatedliteraturereview
AT perveensumera clinicalefficacyofintravenousimmunoglobulinsinmanagementoftoxicshocksyndromeanupdatedliteraturereview
AT chaudhrymuhammadreza clinicalefficacyofintravenousimmunoglobulinsinmanagementoftoxicshocksyndromeanupdatedliteraturereview
AT albabtainsarah clinicalefficacyofintravenousimmunoglobulinsinmanagementoftoxicshocksyndromeanupdatedliteraturereview
AT khansafeera clinicalefficacyofintravenousimmunoglobulinsinmanagementoftoxicshocksyndromeanupdatedliteraturereview

Ejemplares similares